Temozolomide retreatment after desensitization in glioma patients with temozolomide hypersensitivity
Inhibition of MNK pathways enhances cancer cell response to chemotherapy with temozolomide and targeted radionuclide therapy
Tags: alkylating agent, anaplastic astrocytoma, brain cancer, dacarbazine derivative, glioblastoma multiforme, oral chemotherapy drug, prodrug, Temcad®, Temodar®, Temolon®, Temoside®, TMZ
BASi Method Number v
Sign up and you’ll receive the latest updates that matter to you, delivered straight to your inbox.
